Alergología

2013

1. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain

   Pediatric Allergy and Immunology, Vol. 24, Núm. 7, pp. 678-684

2. Antihistamines in drivers, aircrew and occupations of risk.

   Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 27-34

3. Association of thromboxane A1 synthase (TBXAS1) gene polymorphism with acute urticaria induced by nonsteroidal anti-inflammatory drugs

   Journal of Allergy and Clinical Immunology, Vol. 132, Núm. 4, pp. 989-991

4. Bilastine for the treatment of urticaria

   Expert Opinion on Pharmacotherapy, Vol. 14, Núm. 11, pp. 1537-1544

5. ESPRINT-15 questionnaire (Spanish version): Reference values according to disease severity using both the original and the modified ARIA classifications

   Journal of Investigational Allergology and Clinical Immunology, Vol. 23, Núm. 1, pp. 14-19

6. Efficacy of omalizumab in chronic spontaneous urticaria refractory to conventional therapy: Analysis of 110 patients in real-life practice

   Expert Opinion on Biological Therapy, Vol. 13, Núm. 9, pp. 1225-1228

7. Evaluation of the effect of pollution and fungal disease on pinus radiata pollen allergenicity

   International Archives of Allergy and Immunology, Vol. 160, Núm. 3, pp. 241-250

8. H1 antihistamines and benzodiazepines. Pharmacological interactions and their impact on cerebral function.

   Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 17-26

9. In vivo and in vitro techniques in the diagnosis of lipid transfer protein sensitization

   Annals of Allergy, Asthma and Immunology, Vol. 111, Núm. 6, pp. 571-573

10. Managing paediatric anaphylaxis

    US Respiratory Disease, Vol. 8, Núm. 2, pp. 101-107

11. Use of second generation H1 antihistamines in special situations.

    Journal of investigational allergology & clinical immunology, Vol. 23 Suppl 1, pp. 1-16